Related Experiment Video
Updated: Aug 24, 2026
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for
Beate Betz1, Andrea R Florl, Hans-Helge Seifert
1Department of Obstetrics and Gynecology, Heinrich-Heine-University, Duesseldorf, Germany.
Abstract:
Aberrant promoter hypermethylation of CpG dinucleotides is a frequent and significant mechanism of tumor suppressor gene (TSG) silencing in cancer. As increasing numbers of downregulated putative TSGs are emerging from large-scale expression profiling studies, high-throughput techniques are needed to screen for hypermethylation. DHPLC has been established as a reliable, highly sensitive technique for mutation analysis. In this study, the use of DHPLC as a prescreening method for the identification of CpG methylation was developed by analyzing DNA samples with different, well-characterized methylation patterns of the CDKN2A/p16 promoter. Bisulfite treatment of genomic DNA was followed by PCR-amplification of unmethylated as well as methylated CDKN2A/p16 promoter sequences. PCR products were denatured and renatured, permitting the formation of heteroduplex DNA detectable by DHPLC. Methylation of all CpG-sites results in a single peak (homoduplex) with a shift in retention time, whereas partial methylation can be recognized by additional signals representing diverse heteroduplex structures. After method development, 35 DNA samples from primary bladder and breast carcinomas were analyzed in a blinded fashion, revealing complete or partial methylation of the p16 promoter in eight cases and a heterozygous mutation in one case. In conclusion, DHPLC is a highly sensitive and convenient method for methylation screening.
Insights
This study introduces Denaturing High-Performance Liquid Chromatography (DHPLC) as a sensitive method for detecting CpG methylation in tumor suppressor genes. DHPLC effectively screens for promoter hypermethylation, a key mechanism in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant promoter hypermethylation of CpG dinucleotides is a significant mechanism for tumor suppressor gene (TSG) silencing in cancer.
- Large-scale expression profiling studies are identifying increasing numbers of downregulated TSGs, necessitating high-throughput screening methods for hypermethylation.
- Denaturing High-Performance Liquid Chromatography (DHPLC) is an established, sensitive technique for mutation analysis.
Purpose of the Study:
- To develop and validate DHPLC as a prescreening method for identifying CpG methylation.
- To analyze the methylation status of the CDKN2A/p16 promoter using DHPLC.
Main Methods:
- Genomic DNA samples with known methylation patterns of the CDKN2A/p16 promoter were analyzed.
- DNA underwent bisulfite treatment, followed by PCR amplification of methylated and unmethylated promoter sequences.
- PCR products were denatured and renatured to form heteroduplex DNA, detectable by DHPLC.
- DHPLC analysis identified methylation based on homoduplex shifts and heteroduplex signals indicating partial methylation.
Main Results:
- The DHPLC method successfully distinguished between methylated and unmethylated CDKN2A/p16 promoter sequences.
- Analysis of 35 primary bladder and breast carcinoma DNA samples revealed complete or partial methylation of the p16 promoter in eight cases.
- One case showed a heterozygous mutation, also detectable by the method.
Conclusions:
- DHPLC is a highly sensitive and convenient method for screening CpG methylation.
- This technique can aid in the identification of hypermethylated tumor suppressor genes in cancer samples.
- DHPLC offers a valuable tool for high-throughput screening in cancer research.
